Oxaliplatin-induced oxidative stress in nervous system-derived cellular models: Could it correlate with in vivo neuropathy?

Free Radical Biology and Medicine

Volumn 61, Issue , 2013, Pages 143-150

  Di Cesare Mannelli, L ^a   Zanardelli, M ^a   Failli, P ^a   Ghelardini, C ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

Author keywords

Astrocyte; Disease modifying agent; Free radicals; HT 29; SH SY5Y; Silibinin

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; CASPASE 3; CYTOCHROME C; DNA; MALONALDEHYDE; OXALIPLATIN; SILIBININ; SUPEROXIDE; SUPEROXIDE DISMUTASE;

ANIMAL CELL; ANIMAL CELL CULTURE; ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; ASTROCYTE; CANCER CELL CULTURE; CELL TYPE; CELL VIABILITY; CHEMOTHERAPY; COLON ADENOCARCINOMA; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; HYPOTHESIS; IN VITRO STUDY; LIPID PEROXIDATION; MOUSE; NERVOUS SYSTEM; NEUROPATHY; NEUROTOXICITY; NONHUMAN; OXIDATION; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN CARBONYLATION; RAT; SCREENING TEST; SIGNAL TRANSDUCTION;

RATTUS;

EID: 84877085005     PISSN: 08915849     EISSN: 18734596     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2013.03.019     Document Type: Article

References (41)

1. G. Kannarkat, E.E. Lasher, and D. Schiff Neurologic complications of chemotherapy agents Curr. Opin. Neurol. 20 2007 719 725 (Pubitemid 350085017)
2. S. Wolf, D. Barton, L. Kottschade, A. Grothey, and C. Loprinzi Chemotherapy induced peripheral neuropathy: prevention and treatment strategies Eur. J. Cancer. 44 2008 1507 1515
3. A.A. Argyriou, J. Bruna, P. Marmiroli, and G. Cavaletti Chemotherapy-induced peripheral neurotoxicity (CIPN): an update Crit. Rev. Oncol. Hematol. 82 2012 51 77
4. R.H. Wilson, T. Lehky, R.R. Thomas, M.G. Quinn, M.K. Floeter, and J.L. Grem Acute oxaliplatin induced peripheral nerve hyperexcitability J. Clin. Oncol. 20 2002 1767 1774 (Pubitemid 34273265)
5. A. De Gramont, A. Figer, M. Seymour, M. Homerin, A. Hmissi, J. Cassidy, C. Boni, H. Cortes-Funes, A. Cervantes, G. Freyer, D. Papamichael, N. Le Bail, C. Louvet, D. Hendler, F. de Braud, C. Wilson, F. Morvan, and A. Bonetti Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer J. Clin. Oncol. 18 2000 2938 2947 (Pubitemid 30644117)
6. J. Souglakos, D. Mavroudis, S. Kakolyris, C.H. Kourousis, N. Vardakis, N. Androulakis, S. Agelaki, K. Kalbakis, D. Tsetis, N. Athanasiadis, G. Samonis, and V. Georgoulias Triplet combination with irinotecan plus oxaliplatin plus continuous-infusion fluorouracil and leucovorin as first-line treatment in metastatic colorectal cancer: a multicenter phase II trial J. Clin. Oncol. 20 2002 2651 2657 (Pubitemid 34575637)
7. T.J. Kaley, and L.M. Deangelis Therapy of chemotherapy-induced peripheral neuropathy Br. J. Haematol. 145 2009 3 14
8. J.W. Albers, V. Chaudry, G. Cavaletti, and R.C. Donehower Intervention for preventive neuropathy caused by cisplatin and related compound Cochrane Database Syst. Rev. 2 2011 CD005228
9. L. Di Cesare Mannelli, M. Zanardelli, P. Failli, and C. Ghelardini Oxaliplatin-induced neuropathy: oxidative stress as pathological mechanism: protective effect of silibinin J. Pain 13 2012 276 284
10. M. Norcini, E. Vivoli, N. Galeotti, E. Bianchi, A. Bartolini, and C. Ghelardini Supraspinal role of protein kinase C in oxaliplatin-induced neuropathy in rat Pain 146 2009 141 147
11. K. Thibault, B. Calvino, S. Dubacq, M. Roualle-de-Rouville, V. Sordoillet, I. Rivals, and S. Pezet Cortical effect of oxaliplatin associated with sustained neuropathic pain: exacerbation of cortical activity and down-regulation of potassium channel expression in somatosensory cortex Pain 153 2012 1636 1647
12. Di Cesare Mannelli, L.; Bonaccini, L.; Mello, T.; Zanardelli, M.; Pacini, A.; Ghelardini, C. Glia activation along the nervous system during oxaliplatin-dependent neuropathic pain. In: Proceedings of the 8th Ibro World Congress of Neuroscience, Florence, Italy, 14-18 July 2011. URL: http://www.abstractstosubmit.com/ibro2011/abstracts/main.php?do= YToyOntzOjU6Im1vZHVsIjtzOjY6ImRldGFpbCI7czo4OiJkb2N1bWVudCI7aToyMTA2O30= &psArchive=n60l5eh3g246423qgrflm6nkm1;.
13. F. Marchand, M. Perretti, and S.B. McMahon Role of the immune system in chronic pain Nat. Rev. Neurosci. 6 2005 521 532 (Pubitemid 40942819)
14. J. Scholz, and C.J. Woolf The neuropathic pain triad: neurons, immune cells and glia Nat. Neurosci. 10 2007 1361 1368 (Pubitemid 350014681)
15. J.L. Biedler, S. Roffler-Tarlov, M. Schachner, and L.S. Freedman Multiple neurotransmitter synthesis by human neuroblastoma cell lines and clones Cancer Res. 38 1978 3751 3757 (Pubitemid 9045201)
16. M. Sharma, P. Sharma, and H.C. Pant CDK-5-mediated neurofilament phosphorylation in SHSY5Y human neuroblastoma cells J. Neurochem. 73 1999 79 86 (Pubitemid 29289113)
17. A.K. Mantha, M. Dhiman, G. Taglialatela, R.J. Perez-Polo, and S. Mitra Proteomic study of amyloid beta (25-35) peptide exposure to neuronal cells: impact on APE1/Ref-1's protein-protein interaction J. Neurosci. Res. 90 2012 1230 1239
18. K.D. McCarthy, and J. de Vellis Preparation of separate astroglial and oligodendroglial cell cultures from rat cerebral tissue J. Cell Biol. 85 1980 890 902 (Pubitemid 10007455)
19. H. Pan, P. Mukhopadhyay, M. Rajesh, V. Patel, B. Mukhopadhyay, B. Gao, G. Haskó, and P. Pacher Cannabidiol attenuates cisplatin-induced nephrotoxicity by decreasing oxidative/nitrosative stress, inflammation, and cell death J. Pharm. Exp. Ther. 3 2009 708 714
20. M. Disatnik, J.S. Chamberlain, and T.A. Rando Dystrophin mutations predict cellular susceptibility to oxidative stress Muscle Nerve 23 2000 784 792 (Pubitemid 30256611)
21. S.A. Park, K.S. Choi, J.H. Bang, K. Huh, and S.U. Kim Cisplatin-induced apoptotic cell death in mouse hybrid neurons is blocked by antioxidants through suppression of cisplatin-mediated accumulation of p53 but not of Fas/Fas ligand J. Neurochem. 75 2000 946 953 (Pubitemid 30660482)
22. R. Nassini, M. Gees, S. Harrison, G. De Siena, S. Materazzi, N. Moretto, P. Failli, D. Preti, N. Marchetti, A. Cavazzini, F. Mancini, P. Pedretti, B. Nilius, R. Patacchini, and P. Geppetti Oxaliplatin elicits mechanical and cold allodynia in rodents via TRPA1 receptor stimulation Pain 152 2011 1621 1631
23. Y. Chen, P.H. Chan, and R.A. Swanson Astrocytes overexpressing Cu,Zn superoxide dismutase have increased resistance to oxidative injury Glia 33 2001 343 347 (Pubitemid 32285751)
24. J.H. Choi, D.H. Kim, I.J. Yun, J.H. Chang, B.G. Chun, and S.H. Choi Zaprinast inhibits hydrogen peroxide-induced lysosomal destabilization and cell death in astrocytes Eur. J. Pharmacol. 571 2007 106 115
25. O. Elekes, K. Venema, F. Postema, R. Dringen, B. Hamprecht, and J. Korf Evidence that stress activates glial lactate formation in vivo assessed with rat hippocampus lactography Neurosci. Lett. 208 1996 69 72 (Pubitemid 26128110)
26. E.D. Milligan, and L.R. Watkins Pathological and protective roles of glia in chronic pain Nat. Rev. Neurosci. 10 2009 23 36
27. Y.S. Gwak, J. Kang, G.C. Unabia, and C.E. Hulsebosch Spatial and temporal activation of spinal glial cells: role of gliopathy in central neuropathic pain following spinal cord injury in rats Exp. Neurol. 234 2012 362 372
28. S.S. Shord, S.A. Bernard, C. Lindley, A. Blodgett, V. Mehta, M.A. Churchel, M. Poole, S.L. Pescatore, F.R. Luo, and S.G. Chaney Oxaliplatin biotransformation and pharmacokinetics: a pilot study to determine the possible relationship to neurotoxicity Anticancer Res. 22 2002 2301 2309 (Pubitemid 34857057)
29. S. Jacobs, C.L. McCully, R.F. Murphy, J. Bacher, F.M. Balis, and E. Fox Extracellular fluid concentrations of cisplatin, carboplatin, and oxaliplatin in brain, muscle, and blood measured using microdialysis in nonhuman primates Cancer Chemother. Pharmacol. 65 2010 817 824
30. U. Merkel, U. Wedding, M. Roskos, K. Höffken, and A. Hoffmann Pharmacokinetics of oxaliplatin during chronomodulated infusion in metastatic gastrointestinal cancer patients: a pilot investigation with preliminary results Exp. Toxicol. Pathol. 54 2003 475 479 (Pubitemid 36841193)
31. H. Zheng, W.H. Xiao, and G.J. Bennett Functional deficits in peripheral nerve mitochondria in rats with paclitaxel- and oxaliplatin-evoked painful peripheral neuropathy Exp. Neurol. 232 2011 154 1617
32. D.W. Nicholson, and N.A. Thornberry Apoptosis: life and death decisions Science 299 2003 214 215 (Pubitemid 36125199)
33. E.K. Joseph, and J.D. Levine Caspase signaling in neuropathic and inflammatory pain in the rat Eur. J. Neurosci. 20 2004 2896 2902 (Pubitemid 40007283)
34. L. Di Cesare Mannelli, C. Ghelardini, M. Calvani, R. Nicolai, L. Mosconi, E. Vivoli, A. Pacini, and A. Bartolini Protective effect of acetyl-l-carnitine on the apoptotic pathway of peripheral neuropathy Eur. J. Neurosci. 26 2007 820 827 (Pubitemid 47274617)
35. C.W. Cheung, P.J. Taylor, C.M. Kirkpatrick, D.A. Vesey, G.C. Gobe, C. Winterford, D.L. Nicol, and D.W. Johnson Therapeutic value of orally administered silibinin in renal cell carcinoma: manipulation of insulin-like growth factor binding protein-3 levels BJU Int 100 2007 438 444 (Pubitemid 47036591)
36. Y.S. Hsieh, S.C. Chu, S.F. Yang, P.N. Chen, Y.C. Liu, and K.H. Lu Silibinin suppresses human osteosarcoma MG-63 cell invasion by inhibiting the ERK-dependent c-Jun/AP-1 induction of MMP-2 Carcinogenesis 28 2007 977 987
37. R.P. Singh, and R. Agarwal Prostate cancer chemoprevention by silibinin: bench to bedside Mol. Carcinogen. 45 2006 436 442 (Pubitemid 43865852)
38. M. Provinciali, F. Papalini, F. Orlando, S. Pierpaoli, A. Donnini, P. Morazzoni, A. Riva, and A. Smorlesi Effect of the silybin phosphatidylcholine complex (IdB 1016) on the development of mammary tumors in HER-2/neu transgenic mice Cancer Res. 67 2007 2022 2029 (Pubitemid 46424219)
39. S.C. Chu, H.L. Chiou, P.N. Chen, S.F. Yang, and Y.S. Hsieh Silibinin inhibits the invasion of human lung cancer cells via decreased productions of urokinase-plasminogen activator and matrix metalloproteinase-2 Mol. Carcinogen. 40 2004 143 149
40. K. Ramasamy, and R. Agarwal Multitargeted therapy of cancer by silymarin Cancer Lett. 269 2008 352 362
41. S. Kopetz, D.P. Lesslie, N.A. Dallas, S.I. Park, M. Johnson, N.U. Parikh, M.P. Kim, J.L. Abbruzzese, L.M. Ellis, J. Chandra, and G.E. Gallick Synergistic activity of the SRC family kinase inhibitor dasatinib and oxaliplatin in colon carcinoma cells is mediated by oxidative stress Cancer Res. 69 2009 3842 3849